Literature DB >> 21878635

Group X secreted phospholipase A2 proenzyme is matured by a furin-like proprotein convertase and releases arachidonic acid inside of human HEK293 cells.

Ikram Jemel1, Hiromi Ii, Rob C Oslund, Christine Payré, Anne-Sophie Dabert-Gay, Dominique Douguet, Khaoula Chargui, Sabine Scarzello, Michael H Gelb, Gérard Lambeau.   

Abstract

Among mammalian secreted phospholipases A(2) (sPLA(2)s), group X sPLA(2) has the most potent hydrolyzing activity toward phosphatidylcholine and is involved in arachidonic acid (AA) release. Group X sPLA(2) is produced as a proenzyme and contains a short propeptide of 11 amino acids ending with a dibasic motif, suggesting cleavage by proprotein convertases. Although the removal of this propeptide is clearly required for enzymatic activity, the cellular location and the protease(s) involved in proenzyme conversion are unknown. Here we have analyzed the maturation of group X sPLA(2) in HEK293 cells, which have been extensively used to analyze sPLA(2)-induced AA release. Using recombinant mouse (PromGX) and human (ProhGX) proenzymes; HEK293 cells transfected with cDNAs coding for full-length ProhGX, PromGX, and propeptide mutants; and various permeable and non-permeable sPLA(2) inhibitors and protease inhibitors, we demonstrate that group X sPLA(2) is mainly converted intracellularly and releases AA before externalization from the cell. Most strikingly, the exogenous proenzyme does not elicit AA release, whereas the transfected proenzyme does elicit AA release in a way insensitive to non-permeable sPLA(2) inhibitors. In transfected cells, a permeable proprotein convertase inhibitor, but not a non-permeable one, prevents group X sPLA(2) maturation and partially blocks AA release. Mutations at the dibasic motif of the propeptide indicate that the last basic residue is required and sufficient for efficient maturation and AA release. All together, these results argue for the intracellular maturation of group X proenzyme in HEK293 cells by a furin-like proprotein convertase, leading to intracellular release of AA during secretion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21878635      PMCID: PMC3196088          DOI: 10.1074/jbc.M111.268540

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

Review 1.  Interfacial enzymology: the secreted phospholipase A(2)-paradigm.

Authors:  O G Berg; M H Gelb; M D Tsai; M K Jain
Journal:  Chem Rev       Date:  2001-09       Impact factor: 60.622

2.  Cell-specific expression of group X and group V secretory phospholipases A(2) in human lung airway epithelial cells.

Authors:  M C Seeds; K A Jones; R Duncan Hite; M C Willingham; H M Borgerink; R D Woodruff; D L Bowton; D A Bass
Journal:  Am J Respir Cell Mol Biol       Date:  2000-07       Impact factor: 6.914

3.  On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes.

Authors:  E Valentin; F Ghomashchi; M H Gelb; M Lazdunski; G Lambeau
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

Review 4.  Prostaglandins and leukotrienes: advances in eicosanoid biology.

Authors:  C D Funk
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

5.  Polyarginines are potent furin inhibitors.

Authors:  A Cameron; J Appel; R A Houghten; I Lindberg
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

6.  The basis for k(cat) impairment in prophospholipase A(2) from the anion-assisted dimer structure.

Authors:  T M Epstein; B Z Yu; Y H Pan; S P Tutton; B P Maliwal; M K Jain; B J Bahnson
Journal:  Biochemistry       Date:  2001-09-25       Impact factor: 3.162

7.  Purified group X secretory phospholipase A(2) induced prominent release of arachidonic acid from human myeloid leukemia cells.

Authors:  K Hanasaki; T Ono; A Saiga; Y Morioka; M Ikeda; K Kawamoto; K Higashino; K Nakano; K Yamada; J Ishizaki; H Arita
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

8.  Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.

Authors:  Y Morioka; A Saiga; Y Yokota; N Suzuki; M Ikeda; T Ono; K Nakano; N Fujii; J Ishizaki; H Arita; K Hanasaki
Journal:  Arch Biochem Biophys       Date:  2000-09-01       Impact factor: 4.013

9.  Crystal structure of human group X secreted phospholipase A2. Electrostatically neutral interfacial surface targets zwitterionic membranes.

Authors:  Ying H Pan; Bao-Zhu Yu; Alan G Singer; Farideh Ghomashchi; Gerard Lambeau; Michael H Gelb; Mahendra K Jain; Brian J Bahnson
Journal:  J Biol Chem       Date:  2002-05-25       Impact factor: 5.157

10.  Characterization of group X phospholipase A(2) as the major enzyme secreted by human keratinocytes and its regulation by the phorbol ester TPA.

Authors:  A Schadow; K Scholz-Pedretti; G Lambeau; M H Gelb; G Fürstenberger; J Pfeilschifter; M Kaszkin
Journal:  J Invest Dermatol       Date:  2001-01       Impact factor: 8.551

View more
  16 in total

1.  Group X secretory phospholipase A2 regulates insulin secretion through a cyclooxygenase-2-dependent mechanism.

Authors:  Preetha Shridas; Lubna Zahoor; Kathy J Forrest; Joseph D Layne; Nancy R Webb
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

2.  In vitro anti-Plasmodium falciparum properties of the full set of human secreted phospholipases A2.

Authors:  Carole Guillaume; Christine Payré; Ikram Jemel; Louise Jeammet; Sofiane Bezzine; Gajendra S Naika; James Bollinger; Philippe Grellier; Michael H Gelb; Joseph Schrével; Gérard Lambeau; Christiane Deregnaucourt
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

3.  Ectopically expressed pro-group X secretory phospholipase A2 is proteolytically activated in mouse adrenal cells by furin-like proprotein convertases: implications for the regulation of adrenal steroidogenesis.

Authors:  Joseph D Layne; Preetha Shridas; Nancy R Webb
Journal:  J Biol Chem       Date:  2015-01-26       Impact factor: 5.157

4.  The dual role of group V secretory phospholipase A2 in pancreatic β-cells.

Authors:  Preetha Shridas; Victoria P Noffsinger; Andrea C Trumbauer; Nancy R Webb
Journal:  Endocrine       Date:  2017-08-19       Impact factor: 3.633

5.  Secreted Phospholipase A2 Group X Acts as an Adjuvant for Type 2 Inflammation, Leading to an Allergen-Specific Immune Response in the Lung.

Authors:  Herbert Luke Ogden; Ying Lai; James D Nolin; Dowon An; Charles W Frevert; Michael H Gelb; William A Altemeier; Teal S Hallstrand
Journal:  J Immunol       Date:  2020-04-27       Impact factor: 5.422

Review 6.  Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease.

Authors:  Nhat D Quach; Robert D Arnold; Brian S Cummings
Journal:  Biochem Pharmacol       Date:  2014-06-04       Impact factor: 5.858

7.  Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils.

Authors:  Teal S Hallstrand; Ying Lai; Kathryn A Hooper; Rob C Oslund; William A Altemeier; Gustavo Matute-Bello; Michael H Gelb
Journal:  J Allergy Clin Immunol       Date:  2015-06-30       Impact factor: 10.793

Review 8.  Function of secreted phospholipase A2 group-X in asthma and allergic disease.

Authors:  James D Nolin; Ryan C Murphy; Michael H Gelb; William A Altemeier; William R Henderson; Teal S Hallstrand
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-12-05       Impact factor: 4.698

9.  A new era of secreted phospholipase A₂.

Authors:  Makoto Murakami; Hiroyasu Sato; Yoshimi Miki; Kei Yamamoto; Yoshitaka Taketomi
Journal:  J Lipid Res       Date:  2015-03-24       Impact factor: 5.922

10.  Regulation and function of epithelial secreted phospholipase A2 group X in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William A Altemeier; Cara L Appel; Brian Johnson; Charles W Frevert; Kelly L Hudkins; James G Bollinger; Prescott G Woodruff; Dallas M Hyde; William R Henderson; Michael H Gelb
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.